Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro cytogenicity / micronucleus study
Remarks:
Type of genotoxicity: chromosome aberration
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2010
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2010

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
other: OECD 487 (Draft version)
Deviations:
yes
Remarks:
human peripheral blood lymphocytes
GLP compliance:
yes (incl. QA statement)
Remarks:
The Study was conducted in compliance with Principles of Good Laboratory Practice, Paris 1998, in compliance with the DIRECTIVE 2004/9/EC, the DIRECTIVE 2004/10/EC and with the Slovak Government Act № 67/2010 Coll. and the Slovak Government Decree № 320
Type of assay:
in vitro mammalian cell micronucleus test

Test material

Constituent 1
Chemical structure
Reference substance name:
Sulphamidic acid
EC Number:
226-218-8
EC Name:
Sulphamidic acid
Cas Number:
5329-14-6
Molecular formula:
H3NO3S
IUPAC Name:
sulfamic acid
Test material form:
other:

Method

Target gene:
Micronuclei
Species / strain
Species / strain / cell type:
lymphocytes: human peripheral blood lymphocytes
Details on mammalian cell type (if applicable):
Donors: Blood from two different healthy, non-smoking, young (between 31- 34 years of age) people
(always man and women)

Number: For each test replicate two new donors were available.

Source: Department of Haematology and Transfusiology, Šmidke’s street, Bratislava, SLOVAKIA
Treatment: Whole blood treated with an anti-coagulant (heparin), were added to culture medium
containing a mitogen (e.g. phytohemagglutinin) (PHA) and incubated at 37°C.
Additional strain / cell type characteristics:
not applicable
Metabolic activation:
with and without
Metabolic activation system:
S9 MIX
Test concentrations with justification for top dose:
860, 86, 8.6, 0.86, 0.086, 0.0086, 0.00086, 0 µg / mL of blood cultivated
Vehicle / solvent:
Ultrapure water
Controlsopen allclose all
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
other: Thiotepa (CAS: 52-24-4)
Remarks:
-S9 mix (without metabolic activation); concentration: 2 µg.ml -1
Untreated negative controls:
no
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
cyclophosphamide
Remarks:
+S9 mix (with metabolic activation); concentration: 80 µg.ml -1
Details on test system and experimental conditions:
TEST SYSTEM:
Cell used: human peripheral blood lymphocytes
Donors: Blood from two different healthy, non-smoking, young (between 31- 34 years of age) people (always man and women)
Number: For each test replicate two new donors were available.
Source: Department of Haematology and Transfusiology, Šmidke’s street, Bratislava, SLOVAKIA
Treatment: Whole blood treated with an anti-coagulant (heparin), were added to culture medium containing a mitogen (e.g. phytohemagglutinin) (PHA) and incubated at 37°C.
TEST CONDITIONS:
Cytokinesis blocking substance: cytochalasin B
Its concentration and duration of cell exposure: 6,0 µg/mL (30 µg/5 mL), started from 44 hour of each cultivation during remaining 28 hours.
Solvent/vehicle: Ultrapure water without any side effects. Very good solubility of the substance in the water.
Composition of media: RPMI 1640, BOFES, PHAG
CO2 concentration: The concentration of CO2 = 5% in air volume in the culture incubator INCO 2 with
adjustable automatic control.
Volume of vehicle and test substance added: 200 µL (water + substance).
Incubation temperature: 37 °C
Humidity: 90% provided by 500 mL of sterile ultrapure water.
Incubation time: 72 hours (for each test replicate).
Cell density at seeding: The density of lymphocytes in the blood is given approximately at 100000 /mL. After centrifugation about 10 000 cells was spread on slides and then are fixed and count
Type and composition of metabolic activation system: liver enzyme extract from the liver of male white rats, Sprague-Dawley strain after induction of liver enzymes of animals with polychlorinated biphenyl "Delor 103”.
Composition of the activation mixture S9MIX: NADP, G-6-P, sterile distilled H2O,Na2HPO4.12H2O, KH2PO4, KCl, MgSO4, the cooling solution is added to the S9 liver extract.
Negative control: +S9MIX together with -S9MIX blood cultivated in two parallels with the addition of 200 ml ultra-pure H2O.
Positive controls: -S9 mix (without metabolic activation) + Thiotepa (CAS: 52-24-4); concentration: 2 µg/mL
+S9 mix (with metabolic activation) + Cyclophosphamide (CAS: 50-18-0): 80 µg/mL
Methods of slide preparation:
Slides are individually dipped in warm soapy solution for 2-3 hours, then each piece separately washed thoroughly with a brush and rinse with running water. Thus cleaned slides are individually dipped into sulphuric acid, at least 24 hours (or several days). In sulphuric acid glasses are again, individually, rinsed with running water and then distilled water. Cleaned slides are dipped in denatured alcohol, which are stored until use. Before use of alcohol and selected the appropriate polish cloth. Perfect degreasing and cleanliness of the slides is essential for preparing high-quality native specimens and also for colouring techniques.
Evaluation criteria:
1. Micronucleus diameter is greater than the third of nucleus;
2. Colour and structure of the micronucleus is consistent with the colour and structure of the nucleus;
3. Micronucleus distance from the cell nucleus is no more than 3-4 diameters nucleus
4. Micronucleus is located in the cytoplasm of binucleate cells.
Statistics:
Student’s t - test: the arithmetic mean, standard deviation and statistical significance.

Results and discussion

Test results
Species / strain:
lymphocytes: human peripheral blood lymphocytes
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Remarks:
Cytotoxicity in range finding test was caused by physical effect of the test substance (high pH). The highest test concentration 8600 µg / ml of blood cultivated was excluded immediately, because total coagulation of blood had occurred.
Vehicle controls validity:
valid
Untreated negative controls validity:
not examined
Positive controls validity:
valid
Additional information on results:
Data on pH and osmolality of the treatment medium:
Very high concentration were excluded due to extreme coagulation effect on blood. There was also an evidence (very good cell division in the experiments) that very good buffer capacity of the culture media had occurred. (Detail will be specified in the final report).

Definition of what constitutes a micronucleus:
Origination of micronuclei involves an effect of the chemical reaction with chromosomal DNA at mitosis (at division of cell nucleus). Definition of acceptable cells for analysis: Binucleate lymphocytes; micronucleus is located in the cytoplasm of binucleate cell.

Number of cells with micronuclei and number of micronuclei per cell, given separately for each treated and control culture and defining whether from binucleate or mononucleate cells, where appropriate: All micronuclei are in binucleate cells and, in rare cases, less than 1% two or more
micronuclei are located in one binucleate cell.

Dose-response relationship: Very weak, respectively, increasing of doses of the substance does not increase effect sufficiently.
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Any other information on results incl. tables

Range finding test – 1st test replicate: Dilution factor = 10, final concentration of the test substance in 1 mL blood cultivated (blood + culture medium)

 

8

8600 µg / mL

7

860 µg / mL

6

86 µg / mL

5

8.6 µg / mL

4

0.86 µg / mL

3

0.086 µg / mL

2

0.0086 µg / mL

1

0.00086 µg / mL

 

Cytotoxicity in range finding test was caused by physical effect of the test substance (low pH value). The highest test concentration (8) was excluded immediately, because total coagulation of blood had occurred. The concentrations from 1 to 7 were included in the range finding test.

 

Range Finding test – 1st test replicate

Number of micronuclei -S9 mix: Without metabolic activation

 

Parallel 1

Parallel 2

 

M

W

M

W

Substance

Conc. (µg/mL)

Slide1

S.2

S.3

S.4

Average

S.D.

t-value

P-value(%)

SSR

NC

-

4

1

2

5

3,00

1,83

-

-

-

PC

2

11

11

15

17

13,50

3,00

2,99

0,05

*

TSC7

860

2

7

5

4

4,50

2,08

0,54

0,6

N

TSC6

86

3

4

4

2

3,25

0,96

0,12

0,6

TSC5

8,6

2

5

3

7

4,25

2,22

0,44

0,6

TSC4

0,86

7

7

2

4

5,00

2,45

0,65

0,6

N

TSC3

0,086

6

4

2

6

4,50

1,91

0,57

0,6

N

TSC2

0,0086

4

4

4

5

4,25

0,50

0,66

0,6

N

TSC1

0,00086

3

4

5

4

4,00

0,82

0,50

0,4

N

 

Range Finding test – 1st test replicate

Number of mitoses (MI) -S9 mix: Without metabolic activation

 

Parallel 1

Parallel 2

 

M

W

M

W

 

Substance

Conc. (µg/mL)

Slide 1

S.2

S.3

S.4

Average

S.D.

MI(%)

NC

-

42

71

104

38

63,75

30,60

6,4

PC

2

89

68

35

62

63,50

22,25

6,4

TSC7

860

100

106

44

57

76,75

30,87

7,7

TSC6

86

131

108

84

31

88,50

42,87

8,9

TSC5

8,6

108

73

69

50

75,00

24,18

7,5

TSC4

0,86

115

122

65

67

92,25

30,46

9,2

TSC3

0,086

117

59

30

37

60,75

39,48

6,1

TSC2

0,0086

82

56

33

39

52,50

21,95

5,3

TSC1

0,00086

108

121

51

16

74,00

49,19

7,4

 

Dilution factor for the 2nd and 3rd test replicate = 5

From the range - finding test it was concluded that the highest test concentration in both test replicates was 344 µg/mL.

 

3

344 µg/mL

2

68.8 µg/mL

1

3.8 µg/mL

 

Number of micronuclei -S9 mix Without metabolic activation

 

 

2nd test replicate

3rd test replicate (repeated)

 

 

 

 

 

 

Parallel 1

Parallel 2

Parallel 1

Parallel 2

 

 

 

 

 

 

M

W

M

W

M

W

M

W

 

 

 

 

Subst.

Conc. (µg/mL)

Slide 1

S.2

S.3

S.4

S.5

S.6

S.7

S.8

Average

S.D.

t-value

P-value (%)

NC

-

3

5

1

4

1

3

2

2

2,63

1,41

 

 

PC

2

19

11

14

22

19

13

17

12

15,88

3,94

3,16

0,01

TSC3

44

2

5

5

1

4

4

3

2

3,25

1,49

0,31

>0,6

TSC2

8,6

6

5

4

1

4

5

2

5

4,00

1,69

0,63

0,6

TSC1

3,8

7

3

4

2

3

6

1

3

3,63

2,00

0,41

>0,6

 

Number of mitoses (MI) -S9 mix Without metabolic activation

 

 

2nd test replicate

3rd test replicate (repeated)

 

 

 

 

 

Parallel 1

Parallel 2

Parallel 1

Parallel 2

 

 

 

 

 

M

W

M

W

M

W

M

W

 

 

 

Subst.

Conc. (µg/mL)

Slide 1

S.2

S.3

S.4

S.5

S.6

S.7

S.8

Average

S.D.

MI(%)

NC

-

88

102

67

108

96

127

78

49

2,63

1,41

8,9

PC

2

65

59

30

70

25

73

49

29

15,88

3,94

5,0

TSC3

344

31

61

51

69

94

79

68

59

3,25

1,49

7,7

TSC2

68,6

22

108

55

99

90

76

64

52

4,00

1,69

8,3

TSC1

13,8

84

57

40

65

79

96

46

52

3,63

2,00

6,5

 

Number of micronuclei +S9 mix With metabolic activation

 

 

2nd test replicate

3rd test replicate (repeated)

 

 

 

 

 

 

Parallel 1

Parallel 2

Parallel 1

Parallel 2

 

 

 

 

 

 

M

W

M

W

M

W

M

W

 

 

 

 

Subst.

Conc. (µg/mL)

Slide 1

S.2

S.3

S.4

S.5

S.6

S.7

S.8

Average

S.D.

t-value

P-value (%)

NC

-

4

3

2

1

3

5

3

2

2,88

1,25

 

 

PC

80

14

14

11

12

16

20

12

13

14,00

2,88

3,55

0,01

TSC3

344

4

5

1

3

4

2

4

1

3,00

1,51

0,18

TSC2

68,6

4

5

7

6

1

4

1

3

3,88

2,17

0,48

TSC1

13,8

6

5

2

4

3

3

1

2

3,25

1,67

0,29

 

Number of mitoses (MI) +S9 mix With metabolic activation

 

 

2nd test replicate

3rd test replicate (repeated)

 

 

 

 

 

Parallel 1

Parallel 2

Parallel 1

Parallel 2

 

 

 

 

 

M

W

M

W

M

W

M

W

 

 

 

Subst.

Conc. (µg/mL)

Slide 1

S.2

S.3

S.4

S.5

S.6

S.7

S.8

Average

S.D.

MI(%)

NC

-

34

22

18

20

20

17

30

11

21,50

7,33

2,2

PC

80

19

17

14

16

19

18

12

11

15,75

3,11

1,6

TSC3

344

20

13

15

13

18

15

16

18

16,00

2,51

1,6

TSC2

68,6

27

14

17

22

17

10

10

28

18,13

7,00

1,8

TSC1

13,8

16

17

11

20

13

15

20

14

15,75

3,20

1,6

 

Explanatory notes:

NC -Negative control PC -positive control

MI - mitotic index (number of mitoses) in % * - statistical significant result

** - high statistical significant result *** - very high statistical significant result

S.D. Standard deviation N - statistical not significant result

t - value - calculated t - value from the Student’s test

p - value p-value can be found using a table of values from Student's t-distribution

SSR Statistical significance of result TSC Test substance concentration

M - Man

W - Woman

 

 

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative with metabolic activation
negative without metabolic activation

The test substance sulphamidic acid analyzed in terms of micronucleus test in vitro did not show mutagenic effects on the target test system.